EN    EN  
  
  
  
EUROPEAN  
  
COMMISSION  
  
   
Brussels,  
XXX  
  
  
[…] 
(2016)  
XXX  
  
draft  
  
ANNEX 1  
  
  
  
ANNEX  
  
  
to 
  
COMMISSION REGULATION (EU) …/…  
  
of xxx  
  
amending  the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the  
European Parliament and of the Council concerning the Registration, Evaluation,  
Authorisation and Restriction of Chemicals (REACH) as regards CMR substances  
   
 
1 
 ANNEX  
 
Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:  
(1) In Appendix 2, the following entr ies are  inserted in the table in order of the index numbers  
set out therein:  
'1,2-dichloropropane; propylene dichloride   602-020-00-0 201-152-2 78-87-5  
e-glass microfibres of representative composition; 
[Calcium -aluminium -silicate fibres with random 
orientation  with the following representative 
composition (% given by weight): SiO 2 50.0-56.0 
%, Al 2O3 13.0-16.0 %, B 2O3 5.8-10.0 %, Na 2O 
<0.6 %, K 2O <0.4 %, CaO 15.0 -24.0 %, MgO 
<5.5 %, Fe 2O3 <0.5 %, F 2 <1.0 %. Process: 
typically produced by flame attenuation and 
rotary process. (Additional individual elements 
may be present at low levels; the process list does 
not preclude innovation).]  014-046-00-4 - -'  
 
(2) In Appendix 4, the following entr y is inserted in the table in order of the index number  set 
out therein : 
'3,7-dimethylocta -2,6-dienenitrile  608-067-00-3 225-918-0 5146 -66-7'  
 
(3) In Appendix 5,  
(a) the following entries are inserted in the table in  order of the index number s set out 
therein : 
'brodifacoum (ISO);  
4-hydroxy -3-(3-(4'-bromo -4-biphenylyl) -1,2,3,4 -
tetrahydro -1-naphthyl)coumarin  607-172-00-1 259-980-5 56073 -10-0  
lead powder;  
[particle diameter < 1 mm]  082-013-00-1 231-100-4 7439 -92-1  
lead massive:  
[particle diameter ≥ 1 mm]  082-014-00-7 231-100-4 7439 -92-1'  
(b) the entry  relating to  warfarin; 4-hydroxy -3-(3-oxo-1- phenylbutyl) -coumarin is replaced 
by the following entry : 
'warfarin (ISO);  
4-hydroxy -3-(3-oxo-1- phenylbutyl) -2H-
chromen -2-one; [1]  
(S)-4-hydroxy -3-(3-oxo- 1-phenylbutyl) -2-
benzopyrone; [2]  
(R)-4-hydroxy -3-(3-oxo- 1-phenylbutyl) -2-
benzopyrone [3]  607-056-00-0  
201-377-6 [1] 
226-907-3 [2]  
226-908-9 [3]   
81-81-2 [1] 
5543 -57-7 [2]  
5543 -58-8 [3] '  
 
(4) In Appendix 6 ,  
(a) the following entries are inserted in the table in order of the index numbers  set out therein : 
'tetrahydro -2-furyl -methanol; tetrahydrofurfuryl 603-061-00-7 202-625-6 97-99-4   
 
2 
 alcohol  
gallium arsenide  031-001-00-4 215-114-8 1303 -00-0  
Tributyltin compounds, with the exception of 
those specified elsewhere in this Annex  050-008-00-3 - -  
1,2-benzenedicarboxylic acid, dihexyl ester, 
branched and linear  607-710-00-5 271-093-5 68515 -50-4  
imidazole  613-319-00-0 206-019-2 288-32-4  
bisphenol A; 4,4'-isopropylidenediphenol  604-030-00-0 201-245-8 80-05-7  
phenol, dodecyl -, branched; [1]  
phenol, 2 -dodecyl -, branched; [2]  
phenol, 3 -dodecyl -, branched; [3]  
phenol, 4 -dodecyl -, branched; [4]  
phenol, (tetrapropenyl) derivatives [5]  604-092-00-9 310-154-3 [1]  
 
- [2] 
- [3] 
 
- [4] 
- [5] 121158 -58-5 
[1]  
- [2] 
- [3] 
210555 -94-5 
[4] 
74499 -35-7 [5]   
chlorophacinone (ISO);2 -[(4-
chlorophenyl)(phenyl)acetyl] -1H-indene -
1,3(2H) -dione  606-014-00-9 223-003-0 3691 -35-8  
coumatetralyl (ISO); 4-hydroxy -3-(1,2,3,4 -
tetrahydro -1-naphthyl)coumarin  607-059-00-7 227-424-0 5836 -29-3  
difenacoum (ISO); 3 -(3-biphenyl -4-yl-1,2,3,4 -
tetrahydro -1-naphthyl) -4-hydroxycoumarin  607-157-00-X 259-978-4 56073 -07-5  
flocoumafen (ISO); reaction mass of: cis-4-
hydroxy -3-(1,2,3,4 -tetrahydro -3-(4-(4-
trifluoromethylbenzyloxy)phenyl) -1-
naphthyl)coumarin and trans -4-hydroxy -3-
(1,2,3,4 -tetrahydro -3-(4-(4-
trifluoromethylbenzyloxy)phenyl) -1-
naphthyl)coumarin  607-375-00-5 421-960-0 90035 -08-8  
disodium octaborate anhydrous; [1]  
disodium octaborate tetrahydrate [2]  005-020-00-3 234-541-0 [1]  
234-541-0 [2]  12008 -41-2 [1]  
12280 -03-4 [2]   
bromadiolone (ISO); 3 -[3-(4'-bromobiphenyl -4-
yl)-3-hydroxy -1-phenylpropyl] -4-hydroxy -2H-
chromen -2-one 607-716-00-8 249-205-9 28772 -56-7  
difethialone (ISO);  
3-[3-(4'-bromobiphenyl -4-yl)-1,2,3,4 -
tetrahydronaphthalen -1-yl]-4-hydroxy -2H-1-
benzothiopyran -2-one 607-717-00-3 - 104653 -34-1  
perfluorononan -1-oic acid [1]  
and its sodium [2]  
and ammonium [3] salts  607-718-00-9 206-801-3 [1]  
- [2] 
- [3] 375-95-1 [1] 
21049 -39-8 [2] 
4149 -60-4 [3]   
dicyclohexyl phthalate  607-719-00-4 201-545-9 84-61-7  
triflumizole (ISO);  
(1E)-N-[4-chloro -2-(trifluoromethyl)phenyl] -1-
(1H-imidazol -1-yl)-2-propoxyethanimine  612-289-00-6 - 68694 -11-1'   
 
3 
 (b) the entr y relating to flumioxazin (ISO); N -(7-fluoro -3,4-dihydro -3-oxo-4-prop-2-ynyl) —
2,H 1,4 -benzoxazin -6-yl) cyclohex -1-ene-1,2dicarboxamide  is replaced by  the following 
entry:  
 
'flumioxazin (ISO); 2 -[7-fluoro -3-oxo-4- (prop -2-
yn-1-yl)-3,4-dihydro -2H-1,4-benzoxazin -6-yl]-
4,5,6,7 -tetrahydro -1H-isoindole -1,3 (2H) -dione  613-166-00-X - 103361 -09-7'